SELLAS Life Sciences Group, Inc. (SLS) short interest & options flow
NASDAQSELLAS Life Sciences Group has burned through every available share in its lending pool. Cost to borrow has jumped fourfold in a week. Options traders are turning defensive. All three signals arrived on the same day. Availability dropped to 0% on 17 November. Every share in the lending pool is now lent out. That is the tightest reading in the past 52 weeks…
SLS cost to
Full pulse commentary is for ORTEX subscribers. The live data picture for SLS below stays open — short interest, options flow, signals, and historical context.
Sign up free to read pulse →Short interest % of float, cost to borrow, utilization, and put/call ratio for SLS are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
- Market cap
- $1.60B
- Next earnings
- 19 Mar 2027
Key data as of 18 Nov 2026

Latest signals on SLS
- Cost to Borrow
SLS cost to
- Utilization
SLS utilization hits 100%, the highest on record, with availability collapsing to 0.56% of short interest as the stock soars 156% year to date.
7 Utilization updates in 30 days
SLS news and analysis
RSSNo long-form analysis yet for SLS. Pulse alerts and the live data picture are available on ORTEX.
Open SLS on ORTEX →Want the live picture for SLS?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SLS — free to start on ORTEX.
Sign up for free →Open SLS on ORTEX